rss
J Clin Pathol 2006;59:740-743 doi:10.1136/jcp.2005.034330
  • Original article

Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice

  1. M F Dillon1,
  2. C M Quinn2,
  3. E W McDermott1,
  4. A O’Doherty3,
  5. N O’Higgins1,
  6. A D K Hill1
  1. 1Department of Surgery, St Vincent’s University Hospital, Dublin
  2. 2Department of Pathology, St Vincent’s University Hospital
  3. 3Department of Radiology, St Vincent’s University Hospital
  1. Correspondence to:
 A D K Hill
 Department of Surgery, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland; adkhill{at}rcsi.ie
  • Accepted 30 November 2005

Abstract

Background: Core biopsy is considered to be a highly accurate method of gaining a preoperative histological diagnosis of breast cancer. Ductal carcinoma in situ (DCIS) is often impalpable and is a more subtle form of breast cancer.

Aim: To investigate the accuracy of core biopsy in the diagnosis of cancer in patients with DCIS.

Methods: All patients who had invasive cancer (n = 959) or DCIS (n = 92) that was confirmed by excision between 1999 and 2004 were identified. The diagnostic methods, histology of the core biopsy specimen and excision histology were reviewed in detail.

Results: Core biopsy was attempted in 88% (81/92) of patients with DCIS and in 91% (874/959) of those with invasive disease. Of those patients who underwent core biopsy, a diagnosis of carcinoma on the initial core was made in 65% (53/81) of patients with DCIS compared with 92% (800/874) of patients with invasive disease (p<0.0001). Smaller lesion size (p = 0.005) and lower grade (p = 0.03) were associated with increased risk for a negative or non-diagnostic core in patients with DCIS. The nature of the mammographic lesion or the method of biopsy did not affect the probability of an accurate core biopsy. Patients who had a preoperative diagnosis of DCIS by core biopsy had a reoperation rate of 36% compared with 65% of those that did not have a preoperative diagnosis (p = 0.007).

Conclusion: Although core biopsies are highly accurate forms of obtaining a preoperative diagnosis in patients with invasive breast cancer, this is not the case in DCIS. As the number of surgical procedures can be reduced by core biopsy, it is still of considerable value in the management of DCIS.

Footnotes

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.